Integrated Liquid Biopsy Solutions to Accelerate Global Clinical Trials & CDx Development
- Genomic profiling using blood and urine to enable global clinical trials and CDx development
- Epigenomic methylation profiling for enhanced detection of therapy response dynamics and resistance mechanisms
- RNA profiling to advance next-generation drug development through transcriptomic insights